Global Pharmaceutical Isolator Market - Industry Trends and Forecast to 2029
- Published Date: 2022-12-22
- Report ID: 143022
- Pages: 225
-
Format:
Short Description
Global Pharmaceutical Isolator Market, By Type (Aseptic Isolators, Containment Isolators, Bio Isolators, Sampling And Weighing Isolators, Active Pharmaceutical Ingredient (API) Manufacturing Isolators, Radiopharmaceutical Isolators, Production Isolators, Others), System Type (Closed System, Open System), Pressure (Positive Pressure, Negative Pressure), Configuration (Floor Standing, Modular, Mobile, Compact, Table Top, Portable, Others), Application (Sterility Testing, Manufacturing , Sampling/ Weighing/ Distribution , Medical Device Manufacturing, Others), End User (Hospitals, Diagnostic Laboratories, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Others), Distribution Channel (Direct Tender, Retail Sales, Third Party Distributors) Industry Trends and Forecast to 2029.
Market Definition
The isolation concept is quite known in the pharmaceutical industry, protects the process from the Operator and or the operator from the process, while protecting the environment. The key to containment, is minimal exposure. By controlling the exposure range below the hazard level set for the compound, the Operator and the environment are properly protected. Hence, the product is protected and therefore a key regulatory issue is addressed. A pharmaceutical isolator is a sealed bacterial enclosure used in the pharmaceutical surrounding for aseptic filling and toxic process. It is made of a perfectly sterile main isolator where the products are handled, stored or packaged using shoulder-high gloves placed on one of the walls. The pharmaceutical isolator enables the control and containment of pharmaceutical processes. The conditions required for working of a pharmaceutical isolator are sterile environment and free of viable microorganisms. A pharmaceutical isolator ensures that production area and aseptic environment are placed in separate positions.
A pharmaceutical industry isolator is cost effective and efficient, in comparison to cleanrooms for the pharmaceutical industry in an aseptic environment. It creates a controlled atmosphere during the microbial and drug production process by adjusting with the different standards certification standard required for isolators and restricted access barriers. It ensures the protection of the product, the operators and the environment at the same time.
The abundant applications of pharmaceutical isolators, vary for production and control purposes. It is used while handling, transferring or packing solid semi-solid or powder pharma drugs, handling and filing solutions and infusions. The pharmaceutical isolators are applied in sterility testing, aseptic handling of tissues or biological production systems or pathogenic samples, etc. It can be used for the production and control of drugs and pharmaceutical products.
The surge in demand for the isolators across pharmaceutical and biotechnology industry, along with low operational cost, high maintenance of aseptic condition in the production of pharmaceutical products and growing demand of biopharmaceutical industry are the factors expected to drive the market growth, in the forecast period.
Also, strategic initiative by market players, technological progressions in pharmaceutical isolators, high sterility assurance and increasing investment for healthcare infrastructure. These factors increase in the demand for pharmaceutical isolators market.
Market Segmentation
The Global Pharmaceutical Isolator market is categorized into seven notable segments, which are by type, system type, pressure, configuration, application, end user and distribution channel.
On the basis of type, the global pharmaceutical isolator market is segmented into aseptic isolators, containment isolators, bio isolators, sampling and weighing isolators, active pharmaceutical ingredient (API) manufacturing isolators, radiopharmaceutical isolators, production isolators and others.
On the basis of system type, the global pharmaceutical isolator market is segmented into closed system, open system.
On the basis of pressure type, the global pharmaceutical isolator market is segmented into positive pressure, negative pressure.
On the basis of configuration, the global pharmaceutical isolator market is segmented into floor standing, modular, mobile, compact, table top, portable, others.
On the basis of configuration, the global pharmaceutical isolator market is segmented into floor standing, modular, mobile, compact, table top, portable, others.
On the basis of application, the global pharmaceutical isolator market is segmented into sterility testing, manufacturing , sampling/ weighing/ distribution , medical device manufacturing, others.
On the basis of end user, the global pharmaceutical isolator market is segmented into hospitals, diagnostic laboratories, academic and research institutes, pharmaceutical and biotechnology companies, contract research organizations, others.
On the basis of distribution channel, the global pharmaceutical isolator market is segmented direct tender, retail sales, third party distributors
Market Players
Some of the major players operating in the global pharmaceutical isolator market are:
Getinge AB
cytiva (A subsidiary of Danaher Corporation)
Azbil Corporation
Chiyoda corporation
Hosokawa micron Ltd
Bioquell, An Ecolab Solution (A subsidiary of ecolab
chamunda pharma machinery
COMECER S.p.A. (A subsidiary of ats automation tools)
Envair technology
Esco Micro Pte. Ltd
Fedegari Autoclavi S.P.A
Germfree Laboratories, Inc.
Gelman Singapore
Hect Technologie Gmbh
Iso Tech Design
Iteco Srl
Jacomex
LAF Technologies
MBRAUN.
Nuaire
Steriline
Schematic Engineering Industry
Skan Ag
Tema Sinergie S.P.A
TABLE OF CONTENTS
1 INTRODUCTION 37
1.1 OBJECTIVES OF THE STUDY 37
1.2 MARKET DEFINITION 37
1.3 OVERVIEW OF THE GLOBAL PHARMACEUTICAL ISOLATOR MARKET 38
1.4 CURRENCY AND PRICING 40
1.5 LIMITATIONS 40
1.6 MARKETS COVERED 40
2 MARKET SEGMENTATION 45
2.1 MARKETS COVERED 45
2.2 GEOGRAPHICAL SCOPE 46
2.3 YEARS CONSIDERED FOR THE STUDY 47
2.4 DBMR TRIPOD DATA VALIDATION MODEL 48
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 51
2.6 MULTIVARIATE MODELLING 52
2.7 MARKET APPLICATION COVERAGE GRID 53
2.8 SOURCE LIFELINE CURVE 54
2.9 DBMR MARKET POSITION GRID 55
2.10 VENDOR SHARE ANALYSIS 57
2.11 SECONDARY SOURCES 58
2.12 ASSUMPTIONS 58
3 EXECUTIVE SUMMARY 59
4 PREMIUM INSIGHT 63
4.1 PESTEL ANALYSIS 65
4.2 PORTERS FIVE FORCES 66
4.3 INDUSTRIAL INSIGHTS: 67
5 GLOBAL PHARMACEUTICAL ISOLATORS MARKET: REGULATIONS 69
6 MARKET OVERVIEW 73
6.1 DRIVERS 75
6.1.1 GROWING DEMAND FOR THE PHARMACEUTICAL ISOLATORS ACROSS BOOMING PHARMACEUTICAL 75
6.1.2 LOW OPERATIONAL COST OF PHARMACEUTICAL ISOLATORS 75
6.1.3 HIGH MAINTENANCE OF ASEPTIC CONDITIONS IN THE PRODUCTION OF PHARMACEUTICAL PRODUCTS 76
6.1.4 LOW OPERATING COST OF PHARMACEUTICAL ISOLATORS & GROWING DEMAND IN THE BIOPHARMACEUTICAL INDUSTRY 76
6.2 RESTRAINTS 77
6.2.1 STRINGENT GOVERNMENTAL REGULATIONS 77
6.2.2 HIGH COST OF INSTALLATION & LIMITED ADOPTION OF RABS 77
6.3 OPPORTUNITIES 78
6.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS 78
6.3.2 TECHNOLOGICAL ADVANCEMENTS IN PHARMACEUTICAL ISOLATORS 78
6.3.3 HIGH STERILITY ASSURANCE 79
6.4 CHALLENGES 79
6.4.1 LACK OF SKILLED EXPERTISE 79
6.4.2 ENGINEERING CHALLENGES FACED WHILE DESIGNING THE PHARMACEUTICAL ISOLATORS 80
7 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY TYPE 81
7.1 OVERVIEW 82
7.2 ASEPTIC ISOLATOR 85
7.3 ACTIVE PHARMACEUTICAL INGREDIENT (API) MANUFACTURING ISOLATORS 85
7.4 CONTAINMENT ISOLATORS 86
7.5 BIO ISOLATORS 86
7.6 SAMPLING AND WEIGHING ISOLATORS 87
7.7 RADIOPHARMACEUTICAL ISOLATORS 87
7.8 PRODUCTION ISOLATORS 88
7.9 OTHERS 88
8 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE 89
8.1 OVERVIEW 90
8.2 OPEN SYSTEM 93
8.3 CLOSED SYSTEM 93
9 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE 94
9.1 OVERVIEW 95
9.2 POSITIVE PRESSURE 98
9.3 NEGATIVE PRESSURE 98
10 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION 99
10.1 OVERVIEW 100
10.2 FLOOR STANDING 103
10.3 MODULAR 103
10.4 MOBILE 104
10.5 COMPACT 104
10.6 TABLE TOP 105
10.7 PORTABLE 105
10.8 OTHERS 106
11 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION 107
11.1 OVERVIEW 108
11.2 STERILITY TESTING 111
11.3 MANUFACTURING 111
11.4 SAMPLING/WEIGHING/DISTRIBUTION 112
11.5 MEDICAL DEVICE MANUFACTURING 112
12 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL 113
12.1 OVERVIEW 114
12.2 DIRECT TENDER 117
12.3 RETAIL SALES 117
12.4 THIRD PARTY DISTRIBUTORS 118
13 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY END USER 119
13.1 OVERVIEW 120
13.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 123
13.2.1 STERILE FILTERING 123
13.2.2 AMPULE FILLING 123
13.2.3 SYRINGE FILLING 124
13.2.4 SAMPLING 124
13.2.5 SAMPLE TESTING 124
13.2.6 STERILITY TESTING 124
13.2.7 PACKAGING 124
13.2.8 OTHERS 124
13.3 CONTRACT RESEARCH ORGANIZATION 124
13.3.1 STERILE FILTERING 125
13.3.2 AMPULE FILLING 125
13.3.3 SYRINGE FILLING 125
13.3.4 SAMPLING 125
13.3.5 SAMPLE TESTING 125
13.3.6 STERILITY TESTING 125
13.3.7 PACKAGING 126
13.3.8 OTHERS 126
13.4 ACADEMIC AND RESEARCH INSTITUTES 126
13.4.1 STERILE FILTERING 127
13.4.2 AMPULE FILLING 127
13.4.3 SYRINGE FILLING 127
13.4.4 SAMPLING 127
13.4.5 SAMPLE TESTING 127
13.4.6 STERILITY TESTING 127
13.4.7 PACKAGING 127
13.4.8 OTHERS 127
13.5 HOSPITALS 128
13.5.1 STERILE FILTERING 128
13.5.2 AMPULE FILLING 128
13.5.3 SYRINGE FILLING 129
13.5.4 SAMPLING 129
13.5.5 SAMPLE TESTING 129
13.5.6 STERILITY TESTING 129
13.5.7 PACKAGING 129
13.5.8 OTHERS 129
13.6 DIAGNOSTIC LABORATORIES 129
13.6.1 STERILE FILTERING 130
13.6.2 AMPULE FILLING 130
13.6.3 SYRINGE FILLING 130
13.6.4 SAMPLING 130
13.6.5 SAMPLE TESTING 130
13.6.6 STERILITY TESTING 130
13.6.7 PACKAGING 130
13.6.8 OTHERS 131
13.7 OTHERS 131
14 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY REGION 132
14.1 OVERVIEW 133
14.2 NORTH AMERICA 139
14.2.1 U.S. 148
14.2.2 CANADA 153
14.2.3 MEXICO 158
14.3 EUROPE 163
14.3.1 GERMANY 173
14.3.2 FRANCE 178
14.3.3 U.K. 183
14.3.4 ITALY 188
14.3.5 RUSSIA 193
14.3.6 SPAIN 198
14.3.7 TURKEY 203
14.3.8 NETHERLANDS 208
14.3.9 SWITZERLAND 213
14.3.10 BELGIUM 218
14.3.11 REST OF EUROPE 223
14.4 ASIA-PACIFIC 224
14.4.1 CHINA 233
14.4.2 JAPAN 238
14.4.3 SOUTH KOREA 243
14.4.4 INDIA 248
14.4.5 AUSTRALIA 253
14.4.6 SINGAPORE 258
14.4.7 THAILAND 263
14.4.8 MALAYSIA 267
14.4.9 INDONESIA 271
14.4.10 PHILIPPINES 276
14.4.11 REST OF ASIA-PACIFIC 281
14.5 SOUTH AMERICA 282
14.5.1 BRAZIL 291
14.5.2 ARGENTINA 296
14.5.3 REST OF SOUTH AMERICA 301
14.6 MIDDLE EAST & AFRICA 302
14.6.1 SOUTH AFRICA 311
14.6.2 SAUDI ARABIA 316
14.6.3 U.A.E 321
14.6.4 EGYPT 326
14.6.5 ISRAEL 331
14.6.6 REST OF MIDDLE EAST AND AFRICA 336
15 GLOBAL PHARMACEUTICAL ISOLATORS MARKET: COMPANY LANDSCAPE 337
15.1 COMPANY SHARE ANALYSIS: GLOBAL 337
15.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 338
15.3 COMPANY SHARE ANALYSIS: EUROPE 339
15.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 340
16 SWOT ANALYSIS 341
17 COMPANY PROFILE 342
17.1 GETINGE AB 342
17.1.1 COMPANY SNAPSHOT 342
17.1.2 REVENUE ANALYSIS 342
17.1.3 COMPANY SHARE ANALYSIS 343
17.1.4 PRODUCT PORTFOLIO 343
17.1.5 RECENT DEVELOPMENT 343
17.2 CYTIVA (A SUBSIDIARY OF DANAHER CORPORATION) 344
17.2.1 COMPANY SNAPSHOT 344
17.2.2 REVENUE ANALYSIS 344
17.2.3 COMPANY SHARE ANALYSIS 345
17.2.4 PRODUCT PORTFOLIO 345
17.2.5 RECENT DEVELOPMENT 345
17.3 AZBIL CORPORATION 346
17.3.1 COMPANY SNAPSHOT 346
17.3.2 REVENUE ANALYSIS 346
17.3.3 COMPANY SHARE ANALYSIS 347
17.3.4 PRODUCT PORTFOLIO 347
17.3.5 RECENT DEVELOPMENTS 347
17.4 CHIYODA CORPORATION 348
17.4.1 COMPANY SNAPSHOT 348
17.4.2 REVENUE ANALYSIS 348
17.4.3 COMPANY SHARE ANALYSIS 349
17.4.4 PRODUCT PORTFOLIO 349
17.4.5 RECENT DEVELOPMENT 349
17.5 HOSOKAWA MICRON LTD 350
17.5.1 COMPANY SNAPSHOT 350
17.5.2 COMPANY SHARE ANALYSIS 350
17.5.3 PRODUCT PORTFOLIO 351
17.5.4 RECENT DEVELOPMENTS 351
17.6 BIOQUELL, AN ECOLAB SOLUTION (A SUBSIDIARY OF ECOLAB) 352
17.6.1 COMPANY SNAPSHOT 352
17.6.2 REVENUE ANALYSIS 352
17.6.3 PRODUCT PORTFOLIO 353
17.6.4 RECENT DEVELOPMENT 353
17.7 CHAMUNDA PHARMA MACHNIERY 354
17.7.1 COMPANY SNAPSHOT 354
17.7.2 PRODUCT PORTFOLIO 354
17.7.3 RECENT DEVELOPMENTS 354
17.8 COMECER S.P.A. (A SUBSIDIARY OF ATS AUTOMATION TOOLS) (2021) 355
17.8.1 COMPANY SNAPSHOT 355
17.8.2 REVENUE ANALYSIS 355
17.8.3 PRODUCT PORTFOLIO 356
17.8.4 RECENT DEVELOPMENT 358
17.9 ENVAIR TECHNOLOGY 359
17.9.1 COMPANY SNAPSHOT 359
17.9.2 PRODUCT PORTFOLIO 359
17.9.3 RECENT DEVELOPMENTS 359
17.10 ESCO MICRO PTE. LTD 360
17.10.1 COMPANY SNAPSHOT 360
17.10.2 PRODUCT PORTFOLIO 360
17.10.3 RECENT DEVELOPMENT 361
17.11 FEDEGARI AUTOCLAVI S.P.A 363
17.11.1 COMPANY SNAPSHOT 363
17.11.2 PRODUCT PORTFOLIO 363
17.11.3 RECENT DEVELOPMENTS 363
17.12 GERMFREE LABORATORIES, INC. 364
17.12.1 COMPANY SNAPSHOT 364
17.12.2 PRODUCT PORTFOLIO 364
17.12.3 RECENT DEVELOPMENT 366
17.13 GELMAN SINGAPORE 367
17.13.1 COMPANY SNAPSHOT 367
17.13.2 PRODUCT PORTFOLIO 367
17.13.3 RECENT DEVELOPMENTS 368
17.14 HECT TECHNOLOGIE GMBH (2021) 369
17.14.1 COMPANY SNAPSHOT 369
17.14.2 PRODUCT PORTFOLIO 369
17.14.3 RECENT DEVELOPMENT 369
17.15 ISO TECH DESIGN 370
17.15.1 COMPANY SNAPSHOT 370
17.15.2 PRODUCT PORTFOLIO 370
17.15.3 RECENT DEVELOPMENTS 370
17.16 ITECO SRL 371
17.16.1 COMPANY SNAPSHOT 371
17.16.2 PRODUCT PORTFOLIO 371
17.16.3 RECENT DEVELOPMENT 371
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
